Josh Disbrow | Chairman and Chief Executive Officer |
Richard Eisenstadt | Chief Financial Officer |
Jennifer Kim | Cantor Fitzgerald |
Good afternoon and thank you for joining us for the Aytu BioPharma First Quarter Fiscal 2022 Financial Results Call. With me this afternoon, our Aytu's Chairman and Chief Executive Officer, Josh Disbrow, and Chief Financial Officer Richard Eisenstadt. Aytu BioPharma issued a press release earlier today with the details of the Company's operational and financial results for the fiscal first quarter of 2022. A copy of the press release is available on the news page of the Company's website aytubio.com. I would like to remind everyone that today's call is being recorded, a replay of today's call will be available by using the telephone numbers and conference ID provided in the earnings press release.